Compare STIM & STHO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | STIM | STHO |
|---|---|---|
| Founded | 2003 | 2022 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Real Estate |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 95.6M | 101.5M |
| IPO Year | 2018 | 2022 |
| Metric | STIM | STHO |
|---|---|---|
| Price | $2.02 | $8.48 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $3.00 | N/A |
| AVG Volume (30 Days) | ★ 1.8M | 22.8K |
| Earning Date | 05-05-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 57.25 | 24.73 |
| EPS | ★ N/A | N/A |
| Revenue | $52,776,000.00 | ★ $110,143,000.00 |
| Revenue This Year | $11.10 | N/A |
| Revenue Next Year | $11.92 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.80 | $6.06 |
| 52 Week High | $4.84 | $9.24 |
| Indicator | STIM | STHO |
|---|---|---|
| Relative Strength Index (RSI) | 69.40 | 56.16 |
| Support Level | $1.23 | $8.20 |
| Resistance Level | $2.13 | $8.61 |
| Average True Range (ATR) | 0.14 | 0.20 |
| MACD | 0.05 | 0.01 |
| Stochastic Oscillator | 84.90 | 72.92 |
Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advance Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advance Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address the existing treatment options. The company operates in two segments: medical devices and clinic services.
Star Holdings engages in non-ground lease-related businesses, including real estate finance, operating properties, and land and development. Its portfolio is comprised of its interests in Asbury and Magnolia Green residential development projects, a portfolio of commercial real estate properties, and loans that are being marketed for sale. The Company operates its business through one reportable and operating segment that focuses on realizing value for shareholders by generating cash flows through active asset management and sales of its existing loans, operating properties, and land and development properties.